The World Health Organization has declared tuberculosis a global health emergency.
There is already a TB vaccine given to infants in countries other than the United States but it was developed more than sixty years ago. That vaccine protects babies from the worst forms of TB but it does not protect adolescents and adults from a type of tuberculosis which accounts for most cases of the disease.
Host Don Marsh talked with Dr. Daniel Hoft about a pilot study at Saint Louis University’s Center for Vaccine Development. The goal is to develop a test that would identify the most promising vaccine candidates.
Dr. Hoft is the director of the division of infectious diseases, allergy and immunology at SLU.
